呼吸器物理治疗定位对于急性叶片崩的适当性
Louise Hansell1, Maree Milross2, George Ntoumenopoulos3
1Sydney School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; Physiotherapy Department, Royal North Shore Hospital, Northern Sydney Local Health District, St Leonards, Sydney, Australia.
概括
物理治疗师经常选择错误的位置,以治疗急性叶叶骨骨折症 (ALA). 像胸部X射线和听觉等诊断工具在确定肺气化损失的准确性较低,这凸显了需要更好的评估方法的需要.
科学领域:
- 呼吸系统物理治疗 呼吸系统物理治疗
- 关键护理医学 关键护理医学
- 诊断成像诊断成像的使用
背景情况:
- 定位是一个关键的物理疗法干预急性叶膜脱光症 (ALA).
- 目前的方法,如肺听和胸部X射线 (CXR) 缺乏诊断准确性,无法精确地定位ALA.
- 这种不准确性可能会阻碍物理治疗师有效选择治疗位置.
研究的目的:
- 评估物理治疗师选择的位置与肺超声波 (LUS) 识别的通风损失之间的一致性.
- 为了确定CXR和肺听觉相比LUS的诊断准确度,以确定ALA患者的空气损失.
主要方法:
- 在高等教学医院进行前性队列研究.
- 包括机械通风的成人患有ALA的患者.
- 将物理治疗师的位置与LUS发现进行比较;评估CXR和听觉精度与LUS作为参考标准.
主要成果:
- 只有9.3%的患者接受了适当选择的位置.
- 在CXR和听觉测试中,下叶的真实阳性率最高.
- 肺部听觉显示出更高的灵敏度,而CXR在大多数叶片中提供了更高的特异性.
结论:
- 物理治疗师选择的定位经常不适合ALA管理.
- 肺部听觉和CXR都表现出 ALA 局部化诊断准确度较低.
- 建议整合LUS等先进工具,以提高物理治疗师的诊断能力和治疗选择.
相关概念视频
Acute Respiratory Failure-V
124
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
124
Acute Respiratory Failure-IV
131
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
131
Acute Respiratory Failure-III
162
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
162
Flail Chest-II
160
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
160
Chest Physiotherapy
404
Chest Physiotherapy (CPT) is a therapeutic technique used in respiratory care to improve ventilation, clear bronchial secretions, and enhance the efficiency of respiratory muscles. This therapy includes three primary procedures: postural drainage, percussion, and vibration. It can be performed on spontaneously breathing patients and those who are intubated and mechanically ventilated.
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
404
Acute Respiratory Failure-II
179
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
179


